JP2023524054A5 - - Google Patents
Info
- Publication number
- JP2023524054A5 JP2023524054A5 JP2022566176A JP2022566176A JP2023524054A5 JP 2023524054 A5 JP2023524054 A5 JP 2023524054A5 JP 2022566176 A JP2022566176 A JP 2022566176A JP 2022566176 A JP2022566176 A JP 2022566176A JP 2023524054 A5 JP2023524054 A5 JP 2023524054A5
- Authority
- JP
- Japan
- Prior art keywords
- betacoronavirus
- unit
- epitope
- polynucleotide
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA202070282 | 2020-05-01 | ||
| DKPA202070282 | 2020-05-01 | ||
| DKPA202070293 | 2020-05-06 | ||
| DKPA202070293 | 2020-05-06 | ||
| DKPA202070735 | 2020-11-05 | ||
| DKPA202070735 | 2020-11-05 | ||
| DKPA202070820 | 2020-12-08 | ||
| DKPA202070820 | 2020-12-08 | ||
| DKPA202170069 | 2021-02-15 | ||
| DKPA202170069 | 2021-02-15 | ||
| PCT/EP2021/061602 WO2021219897A1 (en) | 2020-05-01 | 2021-05-03 | Betacoronavirus prophylaxis and therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524054A JP2023524054A (ja) | 2023-06-08 |
| JP2023524054A5 true JP2023524054A5 (https=) | 2024-05-15 |
Family
ID=75870604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566176A Pending JP2023524054A (ja) | 2020-05-01 | 2021-05-03 | ベータコロナウイルスの予防と治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230165952A1 (https=) |
| EP (1) | EP4143210A1 (https=) |
| JP (1) | JP2023524054A (https=) |
| KR (1) | KR20230005962A (https=) |
| CN (1) | CN116096735A (https=) |
| AU (1) | AU2021262521A1 (https=) |
| BR (1) | BR112022021905A2 (https=) |
| CA (1) | CA3176527A1 (https=) |
| IL (1) | IL297621A (https=) |
| MX (1) | MX2022013661A (https=) |
| WO (1) | WO2021219897A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180128545A1 (en) | 2016-11-08 | 2018-05-10 | Berry Metal Company | Modular furnace cooling wall |
| US12384811B2 (en) | 2019-04-05 | 2025-08-12 | Academia Sinica | Sialidase-resistant saccharide and method of making and using the same |
| CN112028978B (zh) * | 2020-09-07 | 2023-06-16 | 重庆医科大学 | 新冠病毒特异性cd8+t细胞表位肽及其应用 |
| BR112023000666A2 (pt) | 2021-04-12 | 2023-10-24 | Academia Sinica | Imunógeno, composição imunogênica, método para induzir uma resposta imune contra um coronavírus 2 da síndrome respiratória aguda grave e uso da composição imunogênica |
| BR112023023260A2 (pt) | 2021-05-10 | 2024-01-30 | Nykode Therapeutics ASA | Vetor, métodos para produzir um vetor e para tratar um sujeito tendo uma doença ou uma doença infecciosa, célula hospedeira, e, composição farmacêutica |
| JP2024518463A (ja) | 2021-05-10 | 2024-05-01 | ナイコード セラピューティクス アルメン アクスイェ セルスカプ | 構築物及び免疫阻害化合物の共発現 |
| TW202334429A (zh) * | 2021-10-01 | 2023-09-01 | 中央研究院 | Sars-cov-2棘蛋白特異性抗體及其用途 |
| CN113801209B (zh) * | 2021-11-16 | 2022-02-11 | 浙江普康生物技术股份有限公司 | 一种具有广谱中和活性的新型冠状病毒重组蛋白及其制备方法 |
| GB202201765D0 (en) * | 2022-02-11 | 2022-03-30 | Virax Biolabs Uk Ltd | Methods |
| CN114832099B (zh) * | 2022-04-08 | 2023-11-28 | 国科宁波生命与健康产业研究院 | 一种用于治疗SARS-CoV-2变异毒株感染的多肽制剂 |
| CN114907452B (zh) * | 2022-04-08 | 2023-07-25 | 国科宁波生命与健康产业研究院 | 一种用于治疗SARS-CoV-2病毒感染的M蛋白多肽 |
| US20260007729A1 (en) * | 2022-08-17 | 2026-01-08 | IMMUNEO Therapeutics GmbH | Immunization against viral infections disease(s) |
| WO2024038157A1 (en) * | 2022-08-17 | 2024-02-22 | PMCR GmbH | Immunization against coronavirus |
| LU102995B1 (en) * | 2022-08-17 | 2024-02-19 | PMCR GmbH | Immunization against coronavirus |
| WO2024044747A2 (en) * | 2022-08-25 | 2024-02-29 | University Of Florida Research Foundation, Inc. | Immunogenic composition and uses thereof |
| WO2024092025A1 (en) | 2022-10-25 | 2024-05-02 | Nykode Therapeutics ASA | Constructs and their use |
| WO2024100196A1 (en) | 2022-11-09 | 2024-05-16 | Nykode Therapeutics ASA | Co-expression of constructs and polypeptides |
| WO2024155907A2 (en) * | 2023-01-20 | 2024-07-25 | Duke University | Epitope-scaffold immunogens for pancoronavirus vaccines |
| WO2024210175A1 (ja) * | 2023-04-07 | 2024-10-10 | 国立大学法人大阪大学 | 濾胞性ヘルパーＴ細胞誘導性ＳＡＲＳ－ＣｏＶ－２スパイクタンパク質の部分ペプチド |
| AU2024252371B2 (en) | 2023-04-08 | 2026-02-12 | Rock Biomedical Inc. | Methods and compositions for dendritic cell targeting nano-delivery |
| US12318485B2 (en) | 2023-04-08 | 2025-06-03 | Rock Biomedical, Inc. | Methods and compositions for targeted delivery by polymersomes |
| WO2024238734A2 (en) | 2023-05-17 | 2024-11-21 | Rock Biomedical Inc. | Mgat1 deficient cells and uses thereof |
| CN119143850A (zh) * | 2024-08-20 | 2024-12-17 | 复旦大学 | 广谱抑制流感病毒的多肽及在预防和/或治疗流感病毒感染中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2531204T3 (es) | 2003-02-25 | 2015-03-11 | Vaccibody As | Anticuerpo modificado |
| JP2013532971A (ja) * | 2010-06-25 | 2013-08-22 | バッシボディ アクスイェ セルスカプ | ホモ二量体タンパク質コンストラクト |
| WO2012159643A1 (en) * | 2011-05-24 | 2012-11-29 | Biontech Ag | Individualized vaccines for cancer |
| BR112014015016B1 (pt) | 2011-12-21 | 2023-10-03 | Nykode Therapeutics ASA | Proteína homodimérica de duas cadeias de aminoácidos idênticas,cadeia de aminoácido, molécula de ácido nucléico, composição farmacêutica,célula hospedeira, método de preparação de uma proteína homodimérica, método de preparação de uma vacina e vacina |
| IL260030B2 (en) * | 2016-01-08 | 2025-12-01 | Nykode Therapeutics ASA | Therapeutic anticancer neoepitope vaccine |
| MA47515A (fr) * | 2017-02-16 | 2019-12-25 | Modernatx Inc | Compositions immunogènes très puissantes |
| EP3678699A1 (en) * | 2017-09-07 | 2020-07-15 | University Of Oslo | Vaccine molecules |
| WO2020176797A1 (en) | 2019-02-27 | 2020-09-03 | Nektar Therapeutics | Immunotherapeutic combination for treating cancer |
| LT3972987T (lt) * | 2020-04-10 | 2023-09-25 | Akston Biosciences Corporation | Antigenui specifinė imunoterapija, skirta sulietiems covid-19 baltymams ir naudojimo būdai |
| WO2021216954A1 (en) * | 2020-04-23 | 2021-10-28 | Alpha Beta Holdings, Llc | Compositions and methods for treating or preventing virus infection |
-
2021
- 2021-05-03 KR KR1020227042131A patent/KR20230005962A/ko active Pending
- 2021-05-03 MX MX2022013661A patent/MX2022013661A/es unknown
- 2021-05-03 AU AU2021262521A patent/AU2021262521A1/en active Pending
- 2021-05-03 JP JP2022566176A patent/JP2023524054A/ja active Pending
- 2021-05-03 US US17/997,407 patent/US20230165952A1/en active Pending
- 2021-05-03 WO PCT/EP2021/061602 patent/WO2021219897A1/en not_active Ceased
- 2021-05-03 CN CN202180032441.8A patent/CN116096735A/zh active Pending
- 2021-05-03 BR BR112022021905A patent/BR112022021905A2/pt unknown
- 2021-05-03 CA CA3176527A patent/CA3176527A1/en active Pending
- 2021-05-03 EP EP21724230.4A patent/EP4143210A1/en active Pending
- 2021-05-03 IL IL297621A patent/IL297621A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524054A5 (https=) | ||
| US12516116B2 (en) | Homodimeric protein constructs | |
| KR20220010478A (ko) | 기도 감염의 치료 또는 예방용 서브유닛 백신 | |
| JP7146926B2 (ja) | Ｃｄ４ヘルパーｔ細胞エピトープの融合ペプチドおよびそのワクチン | |
| CN104981541A (zh) | 具有改进特性的经修饰的卷曲螺旋型蛋白 | |
| CA2457414A1 (en) | Virus coat protein/receptor chimeras and methods of use | |
| WO2013041966A1 (en) | Vaccibodies targeted to cross-presenting dendritic cells | |
| JPH05505616A (ja) | 天然のコンホメーションを保持している精製ｇｐ１２０組成物 | |
| JP2010535504A5 (https=) | ||
| JP2025510320A (ja) | エピトープの組合せ及びその使用、ワクチン構築物、免疫応答を誘導する方法、エピトープを特定する方法 | |
| RU2009115688A (ru) | Иммуногенные гибридные полипептиды против ожирения и композиция вакцин против ожирения, содержащая эти полипептиды | |
| CA2338886A1 (en) | Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response | |
| CN117797252B (zh) | 一种基于dna纳米技术的病毒多肽-蛋白亚单位组合疫苗及其制备方法和应用 | |
| CN114502572A (zh) | 展示副粘病毒和/或肺炎病毒f蛋白的自组装蛋白纳米结构及其用途 | |
| CA2660178C (en) | Promiscuous her-2/neu cd4 t cell epitopes | |
| JP2025510786A5 (https=) | ||
| CN119161495B (zh) | 呼吸道合胞病毒重构多肽及其应用 | |
| CN101191130B (zh) | chIFNGR1基因、其编码的蛋白质及应用 | |
| JP2004518410A5 (https=) | ||
| WO2025064372A1 (en) | Reagents and methods for preventing, treating or limiting henipavirus infection | |
| AU2024347309A1 (en) | Reagents and methods for preventing, treating or limiting henipavirus infection | |
| CN121574211A (zh) | 一种新型冠状病毒重组亚单位抗原及其制备方法和在疫苗中的应用 | |
| CN119978138A (zh) | 包含冠状病毒的保守重组蛋白片段的疫苗组合物及其应用 | |
| RU2024111753A (ru) | Рекомбинантный гибридный белок, полученный из HR-области белка S2 SARS-COV-2, и применение рекомбинантного гибридного белка | |
| AU2022333308A1 (en) | Fusion polypeptide |